Ralfinamide
CAS: 133865-88-0
Ref. 3D-FR98311
| 1mg | Descontinuado | ||
| 2mg | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado |
Informação sobre produto
Nome:
Ralfinamide
Sinónimos:
- (2S)-2-[[[4-[(2-Fluorophenyl)methoxy]phenyl]methyl]amino]propanamide
- (S)-2-[[4-[(2-Fluorobenzyl)oxy]benzyl]amino]propanamide
- N~2~-{4-[(2-fluorobenzyl)oxy]benzyl}-L-alaninamide
- Priralfinamide
- Propanamide, 2-[[[4-[(2-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2S)-
- Propanamide, 2-[[[4-[(2-fluorophenyl)methoxy]phenyl]methyl]amino]-, (S)-
Descrição:
Ralfinamide is a potent and selective blocker of the neuronal sodium channel. It has been shown to inhibit viral replication in cells infected with HIV-1, HSV-2, and vesicular stomatitis virus. Ralfinamide also produces a dose-dependent inhibition of rotarod performance in mice and inhibits acid formation in rat stomachs. This drug has been shown to have pressor effects at high doses and causes whole-cell recordings from neurons to be more sensitive to depolarization by an increase in intracellular chloride ions. Ralfinamide mesylate is a crystalline polymorph that is more soluble than ralfinamide hydrochloride, making it more suitable for oral administration.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
302.34 g/mol
Fórmula:
C17H19FN2O2
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
